Verve Loading... : Investor Sentiment and Bull/Bear Views
Loading chart...
Top Calls
No data yet
Price change since each call, adjusted for long/short direction. Results calculated:
Feed
18:20
Jan 08
Jan 08
Base editing shows good clinical success
Base editing is a promising gene therapy approach because it modifies a patient's existing gene rather than delivering a whole new gene; Beam and Verve are advancing this technology with good clinical success.
MED
About Verve Investor Commentary
Across the available history and selected sources, Buzzberg tracks Verve across 1 sources: 1 bullish vs 0 bearish calls from 1 authors. Historical directional balance: 100% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 1 total trade idea tracked. Latest voices: Scott Gottlieb.